Antiretrovirals plus immunomodulators: didanosine/interferon-alpha combination shows promise.
Folkers
G
G
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D016049:Didanosine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006678:HIV / Q000235:genetics / Q000302:isolation & purification; D016655:HIV Core Protein p24 / Q000097:blood; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D016655:HIV Core Protein p24; D016898:Interferon-alpha; D012367:RNA, Viral; D016049:Didanosine